Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Synthetic Biology Market: By Technology, Enabling Products, By Products ), By Application, and Region Forecast 2019-2030
Synthetic Biology Market size was valued at US$ 9.4 billion in 2023 and is expected to reach US$ 47.4 billion by 2030, at a CAGR of 26% from 2024-2030. Synthetic biology is a new interdisciplinary area of the medical field that involves the application of engineering principles in biology. Synthetic biology combines various disciplines within both domains such as genetic engineering, biotechnology, molecular engineering biophysics, computer engineering, electrical engineering and other various branches for the development of artificial biological systems for research engineering and medical applications.
The design and building of new biological parts, equipment, and systems, as well as the re-design of existing, natural biological systems for practical purposes, are all examples of synthetic biology. Furthermore, it has various applications in industrial enzymes, vaccines and antibody production, bio-based chemicals as well as synthetic biological life science research. Synthetic biology is an evolutionary segment of medical technology and market is in the developing stage. Market players and researchers are actively participating in R&D activities to develop and introduce the revolutionary technologies. Furthermore, government funding and support for the research fuelling the market growth. Pharmaceutical and biotechnology businesses spend a lot of money on research in order to produce breakthrough compounds that will meet the rising needs of the healthcare industry and fight new ailments. Collaboration and acquisitions are key strategies adopted by the market players to boost their market revenue share in market.
Study Period
2024-2030Base Year
2023CAGR
26%Largest Market
North AmericaFastest Growing Market
Asia Pacific
Synthetic biology market is driven by the rapid increase in R&D investments in synthetic biology and adaptation of genetically engineered products and DNA sequencing for the treatment and understanding of the diseases progress. In addition, increase in funding from government in life science research and development and advancements in molecular biology expected to boost the synthetic biology during the forecast period. Furthermore, private institutional contribution to synthetic biology research expected to push the market growth. However, lack of regulatory framework, biosafety and biosecurity issues coupled with government policies may hinder the market growth over the forecast period.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 9.4 billion |
Market Size in 2030 |
US$ 47.4 billion |
Market CAGR |
26% |
By Technology |
|
By Product Type |
|
By Application |
|
By Region |
|
Download Free Sample Report
The synthetic biology market size was valued at US$ 9.4 billion in 2023 and is set to reach US$ 47.4 billion by 2030 at a CAGR of 26% from 2024-2030
Asia Pacific is the fastest-growing for market
The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
1.Executive Summary |
2.Global Synthetic Biology Market Introduction |
2.1.Global Synthetic Biology Market - Taxonomy |
2.2.Global Synthetic Biology Market - Definitions |
2.2.1.Technique |
2.2.2.Preservation |
2.2.3.End-User |
2.2.4.Region |
3.Global Synthetic Biology Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Synthetic Biology Market Analysis, 2019-2023 and Forecast 2024-2030 |
4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Synthetic Biology Market By Technique, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
5.1. Enabled Products |
5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Enabling Products |
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6.Global Synthetic Biology Market By Preservation, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
6.1. Synthetic DNA, |
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. XNA, |
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Chassis Organism |
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7.Global Synthetic Biology Market By End-User, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
7.1. Chemicals, |
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Pharmaceuticals, |
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Biopharmaceuticals, |
7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Agriculture, |
7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Others |
7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8.Global Synthetic Biology Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Synthetic Biology Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
9.1. Technique Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Enabled Products |
9.1.2.Enabling Products |
9.2. Preservation Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Synthetic DNA, |
9.2.2.XNA, |
9.2.3.Chassis Organism |
9.3. End-User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Chemicals, |
9.3.2.Pharmaceuticals, |
9.3.3.Biopharmaceuticals, |
9.3.4.Agriculture, |
9.3.5.Others |
9.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Synthetic Biology Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
10.1. Technique Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Enabled Products |
10.1.2.Enabling Products |
10.2. Preservation Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Synthetic DNA, |
10.2.2.XNA, |
10.2.3.Chassis Organism |
10.3. End-User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Chemicals, |
10.3.2.Pharmaceuticals, |
10.3.3.Biopharmaceuticals, |
10.3.4.Agriculture, |
10.3.5.Others |
10.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
10.4.7. |
11.Asia Pacific (APAC) Synthetic Biology Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
11.1. Technique Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Enabled Products |
11.1.2.Enabling Products |
11.2. Preservation Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Synthetic DNA, |
11.2.2.XNA, |
11.2.3.Chassis Organism |
11.3. End-User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Chemicals, |
11.3.2.Pharmaceuticals, |
11.3.3.Biopharmaceuticals, |
11.3.4.Agriculture, |
11.3.5.Others |
11.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Synthetic Biology Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
12.1. Technique Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Enabled Products |
12.1.2.Enabling Products |
12.2. Preservation Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Synthetic DNA, |
12.2.2.XNA, |
12.2.3.Chassis Organism |
12.3. End-User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Chemicals, |
12.3.2.Pharmaceuticals, |
12.3.3.Biopharmaceuticals, |
12.3.4.Agriculture, |
12.3.5.Others |
12.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Synthetic Biology Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
13.1. Technique Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Enabled Products |
13.1.2.Enabling Products |
13.2. Preservation Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Synthetic DNA, |
13.2.2.XNA, |
13.2.3.Chassis Organism |
13.3. End-User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Chemicals, |
13.3.2.Pharmaceuticals, |
13.3.3.Biopharmaceuticals, |
13.3.4.Agriculture, |
13.3.5.Others |
13.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Agilent Technologies (U.S.) |
14.2.2.Thermo Fisher Scientific Inc. (U.S.) |
14.2.3.GEN9 Inc. (U.S.) |
14.2.4.Novozymes |
14.2.5.Amyris Biotechnologies (U.S.) |
14.2.6.Merck KGaA (Germany) |
14.2.7.Epoch Life Science Inc. (U.S.) |
14.2.8.Intrexon Corporation (U.S.) |
14.2.9.Gevo Inc. (U.S.) |
14.2.10.Gingko Bioworks (U.S) |
14.2.11.Twist Bioscience |
14.2.12.GenScript |
14.2.13.Integrated DNA Technologies, Inc. |
14.2.14.Synthetic Genomics Inc. |
14.2.15.New England Biolabs |
14.2.16.Sangamo Therapeutics, Inc. (U.S.) |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players